Abstract

Phospholipid analogues containing a phosphonate in place of the ester at the sn-2 position have been previously shown to be tight-binding competitive inhibitors of secreted phospholipases A 2 . Variants of these compounds in which the structure of the phospholipid polar head group has been changed were prepared and analyzed as inhibitors of the phospholipases A 2 from the and cobra venom, porcine and bovine pancreas, and human synovial fluid. Kinetic measurements of inhibitor potencies were carried out using negatively charged substrate vesicles under conditions in which the enzyme undergoes catalysis without desorption from the vesicle (scooting mode)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.